These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 14616130

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Modified rush venom immunotherapy in dogs with Hymenoptera hypersensitivity.
    Moore A, Burrows AK, Rosenkrantz WS, Ghubash RM, Hosgood G.
    Vet Dermatol; 2023 Dec; 34(6):532-542. PubMed ID: 37395162
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Expansion of circulating Foxp3+)D25bright CD4+ T cells during specific venom immunotherapy.
    Pereira-Santos MC, Baptista AP, Melo A, Alves RR, Soares RS, Pedro E, Pereira-Barbosa M, Victorino RM, Sousa AE.
    Clin Exp Allergy; 2008 Feb; 38(2):291-7. PubMed ID: 18070166
    [Abstract] [Full Text] [Related]

  • 26. Rapid venom immunotherapy is safe for routine use in the treatment of patients with Hymenoptera anaphylaxis.
    Bernstein JA, Kagen SL, Bernstein DI, Bernstein IL.
    Ann Allergy; 1994 Nov; 73(5):423-8. PubMed ID: 7978535
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Serum tryptase level is a better predictor of systemic side effects than prostaglandin D2 metabolites during venom immunotherapy in children.
    Cichocka-Jarosz E, Sanak M, Szczeklik A, Brzyski P, Gielicz A, Pietrzyk JJ.
    J Investig Allergol Clin Immunol; 2011 Nov; 21(4):260-9. PubMed ID: 21721371
    [Abstract] [Full Text] [Related]

  • 33. Safety profile of hymenoptera venom immunotherapy (VIT) in monosensitized patients: lack of new sensitization to nontreated insect venom.
    Spoerl D, Bircher AJ, Scherer K.
    J Investig Allergol Clin Immunol; 2011 Nov; 21(1):22-7. PubMed ID: 21370719
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Depot extracts for rush venom immunotherapy: A new therapeutic opportunity for Hymenoptera sting allergy.
    Pucci S, Ciccarelli F, De Pasquale T, Illuminati I, D'Alò S.
    Ann Allergy Asthma Immunol; 2018 Sep; 121(3):376-377. PubMed ID: 29908318
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.